Tamami Ukaji

Inhibition of MMP-2-mediated cellular invasion by NF-κB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis

Tamami Ukaji, Yinzhi Lin, Shoshiro Okada et al. · Biochemical and Biophysical Research Communications · 2017 · 24 citations

Breast Oncology, Mammary Gland Development, Medicine +11

Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.

Yuhei Arai, Hironobu Iinuma, Yoko Ikeda et al. · The Journal of Antibiotics · 2012 · 14 citations · Full text

Cancer Cell Migration, Medicine, Antibiotic Adjuvant +10

Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells

Tamami Ukaji, Yinzhi Lin, Kouji Banno et al. · PLoS ONE · 2015 · 11 citations · Full text

Cell Proliferation, Cancer Biology, Tumor Biology +17

Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB

Naoki Koide, Yuichiro Kondo, Erdenezaya Odkhuu et al. · Immunology Letters · 2014 · 11 citations

Molecular Physiology, Signal Transduction, Biochemistry +14

NF‑κB inhibitor DHMEQ inhibits titanium dioxide nanoparticle‑induced interleukin‑1β production: Inhibition of the PM2.5‑induced inflammation model

Hitomi Fukatsu, Naoki Koide, Saeko Tada‐Oikawa et al. · Molecular Medicine Reports · 2018 · 11 citations · Full text

Crystal Structure, Engineering, Lung Inflammation +18